Malu G Tansey, PhD

Job title:
Associate Professor of Physiology (Emory), Adjunt Associate Professor of Physiology (UT)
Organization:
Emory University School of Medicine
UT Southwestern Medical Center
Phone:
404-727-6126
PD Guide Terms:
Etiology
Clinical & Biological Features
Therapeutic Development
Contributions:
Published Contributions:
Circumstances needing stereological cell counting/differentiating dysfunction from loss?
What are the best methods for testing the efficacy of novel neuroprotective therapeutics in pre-clinical models?
21 Jul 2009 11:13 AM EST
There is a need for unbiased estimates of cell numbers, particularly in animal models of PD (or more specifically nigral cell loss) designed to help us learn about mechanisms of the disease and ... 
Responses: 1
Divergent triggers converging on microglia activation and driving chronic neuroinflammation
New Research: H5N1 influenza virus induces PD-relevant neurodegeneration
19 Aug 2009 09:24 PM EST
We concur with Paul Carvey's analyses and interpretation of the recent data on this topic and must add that he beat me to punch (or to the post?) in which we planned to mention both ... 
Optimal time window for evaluating effectiveness of neuroprotective drugs using inflammatory models
What are the best methods for testing the efficacy of novel neuroprotective therapeutics in pre-clinical models?
9 Aug 2009 02:01 PM EST
The optimal window for administration of any drug (anti-inflammatory or other class) being evaluated for neuroprotective effects on nigral DA neurons in pre-clinical models is indeed the $64 ...